Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL
Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Dataset |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | Dai, Hai-ping Kong, Dan-qing Shen, Hong-jie Cui, Wei Wang, Qian Li, Zheng Yin, Jia Kang, Li-qing Yu, Lei Wu, De-pei Tang, Xiao-wen |
description | Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups. |
doi_str_mv | 10.6084/m9.figshare.22604309 |
format | Dataset |
fullrecord | <record><control><sourceid>datacite_PQ8</sourceid><recordid>TN_cdi_datacite_primary_10_6084_m9_figshare_22604309</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_6084_m9_figshare_22604309</sourcerecordid><originalsourceid>FETCH-LOGICAL-d919-aeb4288fed9edec32753f90644b785b8fb48a196a7d79f16fb5bc2e0066f19ea3</originalsourceid><addsrcrecordid>eNo1kM1ugzAQhLn0UKV9gx72BUgNOAYfUdQ_CalVxR2t8TpYMRiBq4h36kMW1OS0OyPNjPRF0VPC9oIV_LmXe2NPc4cT7dNUMJ4xeR_9llrbYP2ADox1BBl4A8fyO66hJecgdDThuIDxzvkLaVAL4PqeaLAtdNRj8KO3FFY1B-qvqQmHeXQ4BNzKYbHk9BpufT_ihGod8j9hVQSKwoVogK8OnD0TlFUFOGjw2zJ09tTFk53Pm_8Q3Rl0Mz1e7y6qX1_q43tcfb59HMsq1jKRMZLiaVEY0pI0tVmaHzIjmeBc5cVBFUbxAhMpMNe5NIkw6qDalBgTwiSSMNtF_L9WY8DWBmrGyfY4LU3Cmo1l08vmxrK5scz-AEcKc94</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>dataset</recordtype></control><display><type>dataset</type><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><source>DataCite</source><creator>Dai, Hai-ping ; Kong, Dan-qing ; Shen, Hong-jie ; Cui, Wei ; Wang, Qian ; Li, Zheng ; Yin, Jia ; Kang, Li-qing ; Yu, Lei ; Wu, De-pei ; Tang, Xiao-wen</creator><creatorcontrib>Dai, Hai-ping ; Kong, Dan-qing ; Shen, Hong-jie ; Cui, Wei ; Wang, Qian ; Li, Zheng ; Yin, Jia ; Kang, Li-qing ; Yu, Lei ; Wu, De-pei ; Tang, Xiao-wen</creatorcontrib><description>Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups.</description><identifier>DOI: 10.6084/m9.figshare.22604309</identifier><language>eng</language><publisher>figshare</publisher><subject>Cancer ; Cell Biology ; FOS: Biological sciences ; FOS: Clinical medicine ; FOS: Health sciences ; Genetics ; Hematology ; Immunology ; Infectious Diseases ; Medicine ; Pharmacology ; Virology</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>776,1888</link.rule.ids><linktorsrc>$$Uhttps://commons.datacite.org/doi.org/10.6084/m9.figshare.22604309$$EView_record_in_DataCite.org$$FView_record_in_$$GDataCite.org$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Dai, Hai-ping</creatorcontrib><creatorcontrib>Kong, Dan-qing</creatorcontrib><creatorcontrib>Shen, Hong-jie</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Li, Zheng</creatorcontrib><creatorcontrib>Yin, Jia</creatorcontrib><creatorcontrib>Kang, Li-qing</creatorcontrib><creatorcontrib>Yu, Lei</creatorcontrib><creatorcontrib>Wu, De-pei</creatorcontrib><creatorcontrib>Tang, Xiao-wen</creatorcontrib><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><description>Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups.</description><subject>Cancer</subject><subject>Cell Biology</subject><subject>FOS: Biological sciences</subject><subject>FOS: Clinical medicine</subject><subject>FOS: Health sciences</subject><subject>Genetics</subject><subject>Hematology</subject><subject>Immunology</subject><subject>Infectious Diseases</subject><subject>Medicine</subject><subject>Pharmacology</subject><subject>Virology</subject><fulltext>true</fulltext><rsrctype>dataset</rsrctype><creationdate>2023</creationdate><recordtype>dataset</recordtype><sourceid>PQ8</sourceid><recordid>eNo1kM1ugzAQhLn0UKV9gx72BUgNOAYfUdQ_CalVxR2t8TpYMRiBq4h36kMW1OS0OyPNjPRF0VPC9oIV_LmXe2NPc4cT7dNUMJ4xeR_9llrbYP2ADox1BBl4A8fyO66hJecgdDThuIDxzvkLaVAL4PqeaLAtdNRj8KO3FFY1B-qvqQmHeXQ4BNzKYbHk9BpufT_ihGod8j9hVQSKwoVogK8OnD0TlFUFOGjw2zJ09tTFk53Pm_8Q3Rl0Mz1e7y6qX1_q43tcfb59HMsq1jKRMZLiaVEY0pI0tVmaHzIjmeBc5cVBFUbxAhMpMNe5NIkw6qDalBgTwiSSMNtF_L9WY8DWBmrGyfY4LU3Cmo1l08vmxrK5scz-AEcKc94</recordid><startdate>20230413</startdate><enddate>20230413</enddate><creator>Dai, Hai-ping</creator><creator>Kong, Dan-qing</creator><creator>Shen, Hong-jie</creator><creator>Cui, Wei</creator><creator>Wang, Qian</creator><creator>Li, Zheng</creator><creator>Yin, Jia</creator><creator>Kang, Li-qing</creator><creator>Yu, Lei</creator><creator>Wu, De-pei</creator><creator>Tang, Xiao-wen</creator><general>figshare</general><scope>DYCCY</scope><scope>PQ8</scope></search><sort><creationdate>20230413</creationdate><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><author>Dai, Hai-ping ; Kong, Dan-qing ; Shen, Hong-jie ; Cui, Wei ; Wang, Qian ; Li, Zheng ; Yin, Jia ; Kang, Li-qing ; Yu, Lei ; Wu, De-pei ; Tang, Xiao-wen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d919-aeb4288fed9edec32753f90644b785b8fb48a196a7d79f16fb5bc2e0066f19ea3</frbrgroupid><rsrctype>datasets</rsrctype><prefilter>datasets</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cancer</topic><topic>Cell Biology</topic><topic>FOS: Biological sciences</topic><topic>FOS: Clinical medicine</topic><topic>FOS: Health sciences</topic><topic>Genetics</topic><topic>Hematology</topic><topic>Immunology</topic><topic>Infectious Diseases</topic><topic>Medicine</topic><topic>Pharmacology</topic><topic>Virology</topic><toplevel>online_resources</toplevel><creatorcontrib>Dai, Hai-ping</creatorcontrib><creatorcontrib>Kong, Dan-qing</creatorcontrib><creatorcontrib>Shen, Hong-jie</creatorcontrib><creatorcontrib>Cui, Wei</creatorcontrib><creatorcontrib>Wang, Qian</creatorcontrib><creatorcontrib>Li, Zheng</creatorcontrib><creatorcontrib>Yin, Jia</creatorcontrib><creatorcontrib>Kang, Li-qing</creatorcontrib><creatorcontrib>Yu, Lei</creatorcontrib><creatorcontrib>Wu, De-pei</creatorcontrib><creatorcontrib>Tang, Xiao-wen</creatorcontrib><collection>DataCite (Open Access)</collection><collection>DataCite</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Dai, Hai-ping</au><au>Kong, Dan-qing</au><au>Shen, Hong-jie</au><au>Cui, Wei</au><au>Wang, Qian</au><au>Li, Zheng</au><au>Yin, Jia</au><au>Kang, Li-qing</au><au>Yu, Lei</au><au>Wu, De-pei</au><au>Tang, Xiao-wen</au><format>book</format><genre>unknown</genre><ristype>DATA</ristype><title>Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL</title><date>2023-04-13</date><risdate>2023</risdate><abstract>Additional file 3: Supplementary Table S1. FISH panels for 7 genes frequently involved in Ph-like ALL. Supplementary Table S2. Panels for targeted RNA sequencing. Supplementary Table S3. A panel of 222 genes detected by next generation sequencing. Supplementary Table S4. Clinical and laboratory data of all Ph-like ALL patients. Supplementary Table S5. Clinical and laboratory data of all Ph+ ALL patients. Supplementary Table S6. Clinical and laboratory data of all B-ALL-others patients. Supplementary Table S7. Statistical results of all groups.</abstract><pub>figshare</pub><doi>10.6084/m9.figshare.22604309</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | DOI: 10.6084/m9.figshare.22604309 |
ispartof | |
issn | |
language | eng |
recordid | cdi_datacite_primary_10_6084_m9_figshare_22604309 |
source | DataCite |
subjects | Cancer Cell Biology FOS: Biological sciences FOS: Clinical medicine FOS: Health sciences Genetics Hematology Immunology Infectious Diseases Medicine Pharmacology Virology |
title | Additional file 3 of CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T01%3A41%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-datacite_PQ8&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=unknown&rft.au=Dai,%20Hai-ping&rft.date=2023-04-13&rft_id=info:doi/10.6084/m9.figshare.22604309&rft_dat=%3Cdatacite_PQ8%3E10_6084_m9_figshare_22604309%3C/datacite_PQ8%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |